Anna Schrempf
Impact in
-
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
Papers in
-
- DNA Repair Mechanisms 3
- Protein Degradation and Inhibitors 2
- CRISPR and Genetic Engineering 2
- Chromatin Remodeling and Cancer 1
- ATP Synthase and ATPases Research 1
- Oncology 4
- PARP inhibition in cancer therapy 3
- Co-authors
- Joanna I. Loizou (4 shared papers)Jana Slyšková (1 shared paper)Vincenzo Costanzo (2 shared papers)Anna De Antoni (1 shared paper)G. Baldi (1 shared paper)Vincenzo Sannino (1 shared paper)Georg E. Winter (2 shared papers)Gerhard F. Ecker (1 shared paper)
In The Last Decade
Anna Schrempf
7 papers receiving 249 citations
Peers
Comparison fields: 5 of 36
- Oncology 116
- Aging 7
- Molecular Biology 219
- Cancer Research 39
- Cell Biology 19
Countries citing papers authored by Anna Schrempf
This map shows the geographic impact of Anna Schrempf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Schrempf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Schrempf more than expected).
Fields of papers citing papers by Anna Schrempf
This network shows the impact of papers produced by Anna Schrempf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Schrempf. The network helps show where Anna Schrempf may publish in the future.
Co-authors
The 25 scholars most cited alongside Anna Schrempf, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 110 | |
| 2 | 2022 | 51 | |
| 3 | 2022 | 47 | |
| 4 | 2021 | 20 | |
| 5 | 2017 | 15 | |
| 6 | 2024 | 6 | |
| 7 | 2021 | 1 |
About Anna Schrempf
Anna Schrempf is a scholar working on Molecular Biology, Oncology, Genetics, Cardiology and Cardiovascular Medicine and Plant Science, having authored 7 papers that have together received 250 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (3 papers), DNA Repair Mechanisms (3 papers), Protein Degradation and Inhibitors (2 papers), BRCA gene mutations in cancer (2 papers), CRISPR and Genetic Engineering (2 papers), Plant Virus Research Studies (1 paper), Chromatin Remodeling and Cancer (1 paper) and ATP Synthase and ATPases Research (1 paper). The work is most often cited by research in Oncology (116 citations), Aging (7 citations), Molecular Biology (219 citations), Cancer Research (39 citations) and Cell Biology (19 citations). Anna Schrempf has collaborated with scholars based in Austria, Italy and Germany. Frequent co-authors include Joanna I. Loizou, Jana Slyšková, Vincenzo Costanzo, Anna De Antoni, G. Baldi, Vincenzo Sannino, Georg E. Winter, Gerhard F. Ecker, Tim Skern and Marcus Wieder. Their work appears in journals such as Science Advances, Trends in cancer, Molecular Cell, Virology and Neuro-Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.